← Back to Search

Peer Support Intervention for COVID-19 Related Mental Health Issues (RIWP+ Trial)

N/A
Waitlist Available
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All Latinx immigrants and African refugees aged 18 and older residing in New Mexico will be eligible to participate.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up all 5 timepoints over 32 months
Awards & highlights

RIWP+ Trial Summary

This trial will test a peer support intervention to help Latinx and Black immigrants and refugees cope with mental health, financial, and stress-related problems caused by the COVID-19 pandemic.

Who is the study for?
This trial is for Latinx immigrants and African refugees aged 18 or older living in New Mexico. It's not open to those who've used certain community services within the last year or have severe mental illness that prevents group participation.Check my eligibility
What is being tested?
The study tests a peer advocacy and social support program called Refugee and Immigrant Well-being Project, aiming to improve mental health, financial stability, and reduce stress among Latinx and Black communities affected by COVID-19.See study design
What are the potential side effects?
Since this intervention involves social support rather than medication, there are no direct medical side effects. However, discussing sensitive topics may cause emotional discomfort.

RIWP+ Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a Latinx immigrant or African refugee over 18 living in New Mexico.

RIWP+ Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~all 5 timepoints over 32 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and all 5 timepoints over 32 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Daily Stressors
Economic Precarity
Physical Health
+1 more
Secondary outcome measures
Access to Resources
Cultural Connectedness
Discrimination
+3 more

RIWP+ Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Refugee & Immigrant Well-being Project (RIWP) InterventionExperimental Treatment1 Intervention
6-month mental health intervention that pairs university students with newcomers to engage in mutual learning, resource mobilization, and social change efforts
Group II: Treatment-as-usual Waitlist Control GroupActive Control1 Intervention
participants recruited from community-based organizations receive usual services from community-based organizations and may participate in RIWP intervention in Year 3
Group III: Random Sample of Latinx ImmigrantsActive Control1 Intervention
random sample comparison group of Latinx immigrants who are NOT randomly assigned to a treatment condition

Find a Location

Who is running the clinical trial?

University of New MexicoLead Sponsor
371 Previous Clinical Trials
3,527,829 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,771 Previous Clinical Trials
2,644,083 Total Patients Enrolled
8 Trials studying Mental Health Disorders
3,066 Patients Enrolled for Mental Health Disorders

Media Library

Refugee and Immigrant Well-being Project (RIWP) Clinical Trial Eligibility Overview. Trial Name: NCT05092542 — N/A
Mental Health Disorders Research Study Groups: Treatment-as-usual Waitlist Control Group, Refugee & Immigrant Well-being Project (RIWP) Intervention, Random Sample of Latinx Immigrants
Mental Health Disorders Clinical Trial 2023: Refugee and Immigrant Well-being Project (RIWP) Highlights & Side Effects. Trial Name: NCT05092542 — N/A
Refugee and Immigrant Well-being Project (RIWP) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05092542 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the Refugee and Immigrant Well-being Project (RIWP) have the FDA's blessing?

"The Refugee and Immigrant Well-being Project (RIWP) is considered safe by our team, who gave it a score of 3. This is because it is a Phase 3 trial, meaning that not only is there some evidence of its efficacy, but that there have also been multiple rounds of testing affirming its safety."

Answered by AI

How many people are the researchers hoping to enroll in this trial?

"Yes, this trial is still recruiting patients according to the most recent information from clinicaltrials.gov. The posting date was October 18th 2021 and the last edit was on May 25th 2022. They are looking for 1200 patients from 1 site."

Answered by AI
~178 spots leftby Aug 2024